Ilsung Is Co., Ltd. (KRX:003120)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,930
+130 (0.82%)
Last updated: May 8, 2025
-19.71%
Market Cap 116.31B
Revenue (ttm) 69.02B
Net Income (ttm) 13.09B
Shares Out 6.97M
EPS (ttm) 1,921.00
PE Ratio 8.69
Forward PE n/a
Dividend 1,500.00 (8.99%)
Ex-Dividend Date Dec 27, 2024
Volume 5,208
Average Volume 6,936
Open 15,800
Previous Close 15,800
Day's Range 15,780 - 15,980
52-Week Range 14,500 - 20,050
Beta -0.41
RSI 62.55
Earnings Date Mar 27, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.